RxDoctor Payments Data
★ My doctorsLook up a doctor →

Jane Gelfand

Family Medicine · Ellisville, MONPI 1770996795

Payments from drug & device makers

$3,132in general payments, 2019–2025

Across 207 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$358
  • Pfizer$259
  • Amgen$258
  • Lilly USA, LLC$239
  • Supernus Pharmaceuticals, Inc.$202
  • Novartis$169
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$3,132100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)25$358
Pfizer18$259
Amgen(2 entities)18$258
Lilly USA, LLC15$239
Supernus Pharmaceuticals, Inc.11$202
Novartis13$169
Novo Nordisk10$161
Johnson & Johnson(2 entities)7$129
Arbor Pharmaceuticals, Inc.12$116
Avanir Pharmaceuticals, Inc.4$95
Antares Pharma, Inc.5$93
AstraZeneca7$90
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$87
Amarin Pharma, Inc.6$84
Abbott4$65
Astellas Pharma US Inc3$59
Takeda Pharmaceuticals U.S.A., Inc.4$56
Otsuka America Pharmaceutical, Inc.3$47
Kowa Pharmaceuticals America, Inc.3$43
Mission Pharmacal Company2$41
Boehringer Ingelheim3$39
Dermira, Inc.2$36
Eisai Inc.2$33
Adlon Therapeutics L.p.2$32
Currax Pharmaceuticals LLC2$29
Teva Pharmaceuticals USA, Inc.2$28
QOL Medical, LLC4$27
Lundbeck LLC1$25
Acella Pharmaceuticals, LLC1$24
Daiichi Sankyo Inc.1$23
Corcept Therapeutics1$20
Regeneron Healthcare Solutions, Inc.1$19
Grifols USA, LLC1$18
Merck1$17
Concordia Pharmaceuticals Inc.1$16
GE HealthCare1$15
Orthogenrx Inc.1$15
Aytu Biopharma, Inc.1$14
GSK1$14
Medtronic1$13
Radius Health, Inc.1$12
Sanofi-aventis U.S. LLC1$12

How this compares

$3,132 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri →

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole13$18,799
EliquisApixaban20$17,752
Armour ThyroidThyroid,pork12$1,096
Gabapentin38$525
Liothyronine Sodium19$517
ProgesteroneProgesterone, Micronized22$515
Levothyroxine Sodium63$449
Rosuvastatin Calcium61$380
Telmisartan11$346
Estradiol16$341
Diclofenac Sodium18$331
Irbesartan33$252
Temazepam20$248
Losartan Potassium42$244
Famotidine30$234

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$47$18,79913 claims
PfizerEliquis$259$17,75220 claims
AbbVieArmour Thyroid$358$1,09612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Ellisville

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →